IMBiologics Corp. (KOSDAQ:493280)
South Korea
· Delayed Price · Currency is KRW 53,700
-2,000 (-3.59%)
At close: Apr 28, 2026
IMBiologics Market Cap
IMBiologics has a market cap or net worth of 793.48 billion as of April 28, 2026.
Market Cap
793.48B
Enterprise Value
n/a
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
53,700.00
Market Cap Chart
Since March 20, 2026, IMBiologics's market cap has decreased from 1.54T to 793.48B, a decrease of -48.37%. That is a compound annual growth rate of -99.79%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 28, 2026 | 793.48B | -48.37% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Inventage Lab | 861.70B |
| Curocell | 938.44B |
| IntoCell | 603.13B |
| Kanaph Therapeutics | 517.17B |
| ROKIT Healthcare | 1,388.16B |
| HansBiomed | 472.76B |
| AprilBio | 1,475.25B |
| JS Link | 1,507.58B |